Search research articles
Contact Us
Filters
Showing results (51-60 of 118) with videos related to
Page
of 12
Sort By:
European Journal of Haematology
|
May 29, 2025
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis
Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, et al.
Scientific Reports
|
August 5, 2018
Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?
Ngai Sze Wong, Tsz Ho Kwan, Owen T Y Tsang, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies
Indranill Basu-Ray, Jing Liu, Xiaoming Jia, et al.
Clinical Hematology International
|
October 1, 2021
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-<i>versus</i>-Host Disease Prophylaxis
Maria Queralt Salas, Arjun Datt Law, Wilson Lam, et al.
British Journal of Haematology
|
September 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis
Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients
Eshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
European Journal of Haematology
|
December 14, 2021
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors
Igor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation
Shruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
European Journal of Haematology
|
July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission
Tommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
Transplantation and Cellular Therapy
|
March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Ayman Sayyed, Carol Chen, Armin Gerbitz, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 118) with videos related to
Sort By:
Page
of 12
European Journal of Haematology
|
May 29, 2025
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis
Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, et al.
Scientific Reports
|
August 5, 2018
Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?
Ngai Sze Wong, Tsz Ho Kwan, Owen T Y Tsang, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies
Indranill Basu-Ray, Jing Liu, Xiaoming Jia, et al.
Clinical Hematology International
|
October 1, 2021
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-<i>versus</i>-Host Disease Prophylaxis
Maria Queralt Salas, Arjun Datt Law, Wilson Lam, et al.
British Journal of Haematology
|
September 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis
Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 6, 2021
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients
Eshrak Al-Shaibani, Rhida Bautista, Jeffrey H Lipton, et al.
European Journal of Haematology
|
December 14, 2021
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors
Igor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation
Shruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
European Journal of Haematology
|
July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission
Tommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
Transplantation and Cellular Therapy
|
March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Ayman Sayyed, Carol Chen, Armin Gerbitz, et al.
Page
of 12